Evidence map›Paper›PMID 32153768›Full record

ArticleToxicology research2019

Nanoparticle induced barrier function assessment at liquid-liquid and air-liquid interface in novel human lung epithelia cell lines.

Lars Leibrock, Sandra Wagener, Ajay Vikram Singh, Peter Laux, Andreas Luch

Open access · bronzeAbstract read
In one paragraph

Article in Toxicology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A multiplex inhalation platform to modelFrontiers in pharmacology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lars LeibrockGerman Federal Institute for Risk Assessment (BfR) , Department of Chemical and Product Safety , Max-Dohrn-Straße 8-10 , 10589 Berlin , Germany . Email: lars.leibrock@bfr.bund.de.ORCID 0000-0003-3582-2170
Sandra WagenerGerman Federal Institute for Risk Assessment (BfR) , Department of Chemical and Product Safety , Max-Dohrn-Straße 8-10 , 10589 Berlin , Germany . Email: lars.leibrock@bfr.bund.de.
Ajay Vikram SinghGerman Federal Institute for Risk Assessment (BfR) , Department of Chemical and Product Safety , Max-Dohrn-Straße 8-10 , 10589 Berlin , Germany . Email: lars.leibrock@bfr.bund.de.ORCID 0000-0003-2657-7935
Peter LauxGerman Federal Institute for Risk Assessment (BfR) , Department of Chemical and Product Safety , Max-Dohrn-Straße 8-10 , 10589 Berlin , Germany . Email: lars.leibrock@bfr.bund.de.ORCID 0000-0002-0351-3392
Andreas LuchGerman Federal Institute for Risk Assessment (BfR) , Department of Chemical and Product Safety , Max-Dohrn-Straße 8-10 , 10589 Berlin , Germany . Email: lars.leibrock@bfr.bund.de.ORCID 0000-0002-5866-901X
Federal Institute for Risk Assessment · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhalation is the most relevant entry point for nanoparticles (NPs) into the human body. To date, toxicity testing of nanomaterials in respect to oral, dermal and inhalative application is mainly based on animal experiments. The development of alternative test methods is the subject of current research.

Identifiers

PMID32153768
PMCPMC7021197
OpenAlexW2990076749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.